Site icon The Source

Pros, Cons, and What You Should Know About Medical Research Preprints

Preprints have become something of a hot-button issue in medical publishing. Though many of us have heard the term, especially within the last 3 years, most people aren’t too familiar with what preprints actually are or their implications for future publication of research.

As defined by the JAMA Network in 2020, a preprint is a full and complete version of a research manuscript that’s made publicly available via upload to a preprint repository server before the manuscript receives any peer review or journal evaluation. Notably, most journals don’t consider preprints to violate the rule of prior publication—that is to say that, even if a manuscript has been publicly uploaded as a preprint, it’s still eligible to be published in full by a peer-reviewed medical journal.

The popularity of preprints rose sharply during the beginning of the COVID-19 pandemic, when scientific understanding of the disease was minimal and timely dissemination of research was crucial. Of the >125000 COVID-19–related manuscripts published in medical journals within 10 months of the first recorded case, over 30000 were originally published as preprints. Though the availability of data and research was instrumental in rapidly building our scientific understanding of the disease, this also meant that faulty and problematic research that hadn’t yet been peer-reviewed was being widely circulated.

The overall impression of preprints, both for COVID-19–related research and non-COVID–related academia, has been mixed, to say the least. To better understand this phenomenon, let’s break down the benefits and drawbacks of preprints.

Now that we have a better understanding of the pros and cons of preprints, let’s turn our attention toward what you need to know about preprints in our contemporary research ecosystem. Considering publishing a preprint? Think about the following:

Exit mobile version